| Literature DB >> 31997039 |
Francesco Macchione1, Leonardo Salviati2,3, Andrea Bordugo4, Monica Vincenzi5, Marta Camilot5, Francesca Teofoli5, Elia Pancheri1, Roberta Zordan2,3, Cinzia Bertolin2,3, Silvia Rossi2,3, Gaetano Vattemi1, Paola Tonin6.
Abstract
Multiple acyl-CoA dehydrogenase deficiency, or glutaric aciduria type II, is an autosomal recessive disorder of fatty acid oxidation due to defects in electron transfer flavoprotein (ETF) encoded by ETFA and ETFB, or in electron transfer flavoprotein dehydrogenase (ETFDH) encoded by the ETFDH gene. The disease may present as a severe neonatal onset form and a mild late-onset form which is heterogeneous for the age at onset and clinical presentation. We describe two patients in their seventies, referred for a nonspecific myopathy, which resulted to manifest carriers of ETFDH gene mutation. Treatment with riboflavin and L-carnitine improved the clinical picture and the biochemical profile. This condition should be included in the differential diagnosis of myopathies even at an old age.Entities:
Keywords: ETFDH gene mutations; Fatty acid oxidation; Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD); Myopathy; Riboflavin treatment
Year: 2020 PMID: 31997039 DOI: 10.1007/s00415-020-09729-z
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849